| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 75,948 | |||
| Investments | 146,810 | |||
| Prepaid expenses and other current assets | 4,922 | |||
| Total current assets | 227,680 | |||
| Property and equipment, gross | 57,213 | |||
| Less accumulated depreciation and amortization | 27,445 | |||
| Property and equipment, net | 29,768 | |||
| Goodwill | 39,154 | |||
| Intangible assets | 25,150 | |||
| Restricted cash | 1,365 | |||
| Deposits | 515 | |||
| Operating lease right-of-use assets, net | 3,653 | |||
| Finance lease right-of-use asset, net | 40,748 | |||
| Total assets | 368,033 | |||
| Accounts payable and accrued expenses | 28,258 | |||
| Operating lease liabilities, current | 1,015 | |||
| Finance lease liability, current | 1,897 | |||
| Total current liabilities | 31,170 | |||
| Operating lease liabilities, non-current | 2,758 | |||
| Finance lease liability, non-current | 19,375 | |||
| Other liabilities | 1,061 | |||
| Total liabilities | 54,364 | |||
| Common stock, 0.01 par value, 180,000,000 shares authorized 108,208,643 and 106,453,818 shares issued and outstanding as of september 30, 2025, and december 31, 2024, respectively | 1,082 | |||
| Additional paid-in capital | 1,711,297 | |||
| Accumulated other comprehensive (loss) income | -9 | |||
| Accumulated deficit | -1,398,701 | |||
| Total stockholders' equity | 313,669 | |||
| Total liabilities and stockholders' equity | 368,033 | |||
ROCKET PHARMACEUTICALS, INC. (RCKTW)
ROCKET PHARMACEUTICALS, INC. (RCKTW)